Linfomas
GLUN
Fondazione IRCCS Istituto Nazionale dei Tumori
Milán, ItaliaPublicacións en colaboración con investigadores/as de Fondazione IRCCS Istituto Nazionale dei Tumori (4)
2023
2021
-
A phase Ib, open-label, dose-escalation trial of the anti-CD37 monoclonal antibody, BI 836826, in combination with gemcitabine and oxaliplatin in patients with relapsed/refractory diffuse large B-cell lymphoma
Investigational New Drugs, Vol. 39, Núm. 4, pp. 1028-1035
2018
2015
-
DNA methylation profiling identifies two splenic marginal zone lymphoma subgroups with different clinical and genetic features
Blood, Vol. 125, Núm. 12, pp. 1922-1931